Padilla-Lopez, M, Manicone, F, Holle, SLD, Wenzl, FA, Kimmoun, A, Mebazaa, A, Sionis, A. Novel treatment strategies in cardiogenic shock: an update on ongoing clinical trials. HEART FAILURE REVIEWS. 2026; 31(1)DOI:10.1007/s10741-026-10637-z. PMID:42095992. IF:4.200(Q1/3D).

Aimo, A, Butler, J, De Michieli, L, Mendieta, G, Zannad, F, Januzzi, JL. Biomarkers for Cardiovascular Drug Development. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2026; 87(15)DOI:10.1016/j.jacc.2025.12.072. PMID:41670555. IF:22.300(Q1/1D).

Vivas, D, Ferrandis, R, Anguita-Sánchez, M, Anguita-Gámez, M, Arcelus, JI, Echeverri, M, Egocheaga, I, Esteve-Pastor, MA, Ferreiro, JL, Llau, JV, Roldán, V, Ruiz-Nodar, JM, González-Casal, D, Torres-Fonseca, M, López-Menéndez, J, Ciria, M, Leyva, F, de Santiago, ER, Vidán, MT, Pamplona, L, Mingot-Castellano, ME, Mateo-Arranz, J, Polo, J, Castellanos, A, Llanos, C, Madridano, O, Jiménez, S, Freijo, MD, Puchades, MJ, Lafuente, J, Jiménez, D, Santos-Bueso, E, Ferrandis, E, Figuero, E, González-Nieto, CJ, Castel, A, Hermida, JF, Marín, F, Rodríguez-Padial, L, Fernández-Lozano, I, Hidalgo, F, Cassinello, C, Muñoz, E, Palomo-López, N. Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(1)DOI:10.1016/j.rec.2025.09.003. PMID:40983168. IF:4.900(Q1/2D).

Revilla, N, Gutierrez, AB, Alén, AR, Martínez, AM, Franco, CA, Díaz, CG, Alonso, CM, Aisa, CS, Jiménez, DF, Espino, EM, Arteta, EG, Jaime, FJL, Ortega, IS, Martíinez, IM, Upegui, I, Pego, JM, Tovar, JC, Vila, JGA, Bastida, JM, Juaristi, KA, Lopez, MR, Rodríguez, MF, Paloma, MJ, Muñoz, MJS, Jubilar, MM, Massaro, MT, Docampo, MF, Miguélez, MSO, Vilalta, N, Sebastian, OG, Culebras, RA, Giner, VC, Villas, JMC, Butta, N. Evaluation of Fibrinolysis Testing Methods in Haemostasis and Thrombosis Laboratories: Results of a National Survey by the Spanish Society on Thrombosis and Haemostasis (SETH) Laboratory Working Group. HAEMOPHILIA. 2026; 32DOI:. PMID:. IF:3.000(Q2/4D).

De la Corte, H, Expósito, MC, De Paz, MR, Ureña, LE, Jaime, FJL, Canaro, M, Coll, J, Candel, FG, Hidalgo, O, Boix, SB, Lucas, J, Vázquez, RN, Mesa, A, Sanchez, VB, Román, TA. Enhancing Physical Activity in Patients Treated With Emicizumab in Hemophilia A: Results From the HEMO-ACT Cross-Sectional Study. HAEMOPHILIA. 2026; 32DOI:. PMID:. IF:3.000(Q2/4D).

Han, JH, ten Cate, V, Li-Gao, R, Robles, AP, Sulochana, HR, Andrade-Navarro, MA, Ao, LJ, Noordam, R, Martinez-Perez, A, Sabater-Lleal, M, Soria, JM, Souto, JC, Rosendaal, FR, Wild, PS, Vlieg, AV. Genome-wide identification of loci associated with plasma coagulation factor IX activity. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2026; 24(2)DOI:10.1016/j.jtha.2025.10.005. PMID:41161418. IF:5.000(Q1/2D).

Vallès-Cardona, G, Caixàs, A, Berges, I, Perea, G, Vilalta, N, Corripio, R. Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk. GENETICS IN MEDICINE. 2026; 28(4)DOI:10.1016/j.gim.2026.102536. PMID:41685566. IF:6.200(Q1/1D).

Rossi-Herring, G, Belmonte, T, Rivas-Urbina, A, Benitez, S, Rotllan, N, Crespo, J, Llorente-Cortes, V, Sanchez-Quesada, JL, de Gonzalo-Calvo, D. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 162DOI:10.1016/j.biopha.2023.114623. PMID:37023624. IF:6.900(Q1/1D).

Bugiardini, R, Gale, CP, Gulati, M, Anand, SS, Maas, AHEM, Townsend, N, Vaccarino, V, Badimon, L, Cenko, E, Manfrini, O, Jha, P. Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health. Lancet Regional Health-Europe. 2024; 41DOI:https://ddd.uab.cat/record/324021. PMID:38725796. IF:13.000(Q1/1D).

Gorog, DA, ten Berg, JM, Campo, G, Geisler, T, Gigante, B, Grove, EL, Halvorsen, S, Huber, K, Jeong, YH, Lip, GYH, Navarese, EP, Rubboli, A, Matula, JMS, Storey, RF, Valgimigli, M, Vandenbriele, C, Vilahur, G, Ahrens, I, Ferreiro, JL. Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuag021. PMID:41914626. IF:4.600(Q1/2D).

Ramos-Regaladoa, L, Schoch, L, Alcovera, S, Magaldi, M, Barriusoa, I, Padróa, T, Borrella, M, Badimona, L, Zaragozad, C, Vilahura, G. Differential regulation of the HIF-1«/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2025.500842. PMID:40816967. IF:(Q/D).

Leader, JH, Vilahur, G, Ajjan, RA, Kanji, R, Gue, YX, Farag, M, Gorog, DA. Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction. CARDIOVASCULAR RESEARCH. 2026; 122(6)DOI:10.1093/cvr/cvag047. PMID:41757699. IF:13.300(Q1/1D).

Preda, A, Tirandi, A, Leo, G, Di Vece, D, Vilahur, G, Bonaventura, A, Osto, E, Ministrini, S, Kraler, S, Kleinbogard, P, Camici, G, Carbone, F, Montecucco, F, Liberale, L. IL-6 in the spotlight: From cardiovascular pathophysiology to therapy. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70161. PMID:41340186. IF:3.600(Q1/2D).

Luquero, A, Pimentel, N, Vilahur, G, Borrell-Pages, M, Badimon, L. LRP5, a WNT signalling pathway receptor, and platelet activation. EUROPEAN HEART JOURNAL. 2026; 47(16)DOI:10.1093/eurheartj/ehaf772. PMID:41042971. IF:35.600(Q1/1D).

Kraler, S, Vilahur, G, Kleinbongard, P. From bile to vessels: linking obesity to endothelial dysfunction. EUROPEAN HEART JOURNAL. 2026; 47(10)DOI:10.1093/eurheartj/ehaf957. PMID:41329862. IF:35.600(Q1/1D).

Matamoros J.F.. Latest report from the ALTAMIRA study of emergency management of vein thrombosis: our departments' strengths and weaknesses. EMERGENCIAS. 2023; 35(2)DOI:. PMID:37038937. IF:5.400(Q1/1D).

Temprano-Sagrera, G, Peypoch, O, Soto, B, Dilmé, J, Juscafresa, LC, Davtian, D, Estadella, MD, Nieto, L, Brown, A, Escudero, JR, Viñuela, A, Camacho, M, Sabater-Lleal, M. Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression. Journal of the American Heart Association. 2024; 13(24)DOI:10.1161/JAHA.124.036082. PMID:39655704. IF:5.300(Q1/2D).

Puertas-Umbert, Lidia, Alonso, Judith, Blanco-Casoliva, Laia, Almendra-Pegueros, Rafael, Camacho, Mercedes, Rodriguez-Sinovas, Antonio, Galan, Maria, Roglans, Nuria, Laguna, Juan Carlos, Martinez-Gonzalez, Jose, Rodriguez, Cristina. Inhibition of ATP-citrate lyase by bempedoic acid protects against abdominal aortic aneurysm formation in mice.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2025; 184DOI:10.1016/j.biopha.2025.117876. PMID:. IF:(Q/D).

Pérez-Armijo, P, Pérez-Esteve, E, Perez-López, A, Gamero, A, Troncoso-Pantoja, C, García-Galbis, MR, Fernández-Villa, T, Lozano-Lorca, M, Kouiti, M, Apolinar-Jimenez, E, Nava-González, EJ, Daga, R, Almendra-Pegueros, R. The growth of Spanish universities teaching the Degree in Human Nutrition and Dietetics: a call for reflection. Revista Espanola De Nutricion Humana Y Dietetica. 2024; 28(3)DOI:10.14306/renhyd.28.3.2318. PMID:. IF:(Q/D).

Masip, M, Pagès-Puigdemont, N, López-Ferrer, A, de Paz, HD, Serra-Baldrich, E, Puig, L, Riera, P. Defining the Care Pathway in Patients with Psoriasis and Atopic Dermatitis. Patient Preference and Adherence. 2024; 18DOI:10.2147/PPA.S489731. PMID:39574936. IF:2.000(Q2/4D).